Supreme’s 7ACRES Continues to Impress
Ash Stringer
November 14th, 2019
Top News
2018 was a stellar year for cannabis advocates as the green rush of marijuana legalization swept the globe, including California, the world’s fifth biggest economy, legalizing recreational marijuana and Canada becoming the first G20 nation to do so; however, 2019 may go down – surprisingly – as the year of a cannabis shake-out. Despite retreating stock prices, some companies are thriving and moving ahead of their peers, achieving brand recognition and increasing recreational sales.
From its headquarters in Toronto, Canada, The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF), continues to develop its formidable portfolio of assets that set it apart from peers, including its foundational asset, the award-winning 7ACRES brand and up-and-coming brand Blissco.
More Awards for the Trophy Case?
7ACRES is widely recognized as a premium brand that commands a premium price. The company’s over 600 skilled employees include seasoned cannabis vets devoted to cultivars with uncompromised aroma and flavor. The bright minds that selected some of the 7ACRES leading strains have now been moved over to Cambium Plant Sciences, a new subsidiary of Supreme Cannabis that will focus on the development and licensing of next generation cannabis plant genetics and cultivation IP.
Click here to receive an investor deck and corporate updates
The quality of the 7ACRES team and product is evident; 7ACRES regularly finds itself at the podium of some of the most well-known cannabis awards in the industry. Amongst other accolades, 7ACRES was named “Craft Grower of the Year” at the Grow Up 2019 Awards, “Brand of the Year” at the 2018 and 2019 Canadian Cannabis Awards and was awarded the “Best Marketing Campaign” of the year at the 2019 O’Cannabiz Awards for its “Respect the Plant” campaign.
On November 8, Lift & Co. hosted the Canadian Cannabis Awards. Once again, 7ACRES received a wide variety of nominations. Rebecca Phillips, Production Director/Master Grower at 7ACRES, was up for “Women in Weed – Trailblazer” and Melanie Carruthers, Master Grower at 7ACRES, was nominated for “Top Master Grower”. For the second year in a row, 7ACRES took home the “Brand of the Year” award.
Consumers Love Premium Goods
7ACRES will not offer low-quality product to consumers. Once thought to be a counterintuitive strategy, the company has proven its model with many of its sell-out premium strains asked for by name throughout Canada.
The strategy actually dovetails perfectly into data showing consumers don’t mind opening their wallets for legal, hand-crafted marijuana. In fact, a study of 724 people published on PubMed concluded that consumers view cannabis sold legally as being of higher quality than that on the black market and that higher prices for legal products won’t impact buying habits to avoid illegal purchases.
Click here to receive an investor deck and corporate updates
This research supports other data that shows 85% of cannabis enthusiasts won’t buy products that have subpar scent and 63% won’t make purchases of marijuana products that don’t pass their visual inspection.
From its 440,000 square-foot indoor hybrid facility, 7ACRES produces best-in-class cannabis. 7ACRES is clearly differentiating itself with higher-quality and higher-priced products. In September, 7ACRES launched its latest high-end brand, Jack Haze, into its extensive distribution network throughout Canada. As 7ACRES’ first sativa dominant strain, Jack Haze – a play on the famous Jack Herer strain – delivers high THC content with a rare terpinolene forward profile.
Blissco Integrated, Diversified Revenue from Wellness Products
Blissco is an established wellness brand as a distributor and retailer in British Columbia producing cannabis oils since August 2018 that is ready to ramp up operations. This month, the company received a new licensing approval from Health Canada for the sale of full spectrum cannabis oil products from its facility in Langley, British Columbia.
After acquiring Blissco earlier this year, Supreme has been nose down integrating and advancing the business, while initiating construction on a commercial-scale ethanol-based extraction lab to expand upon the existing CO2-based extraction facility. The new facility should be completed by the end of the year, with the capacity to produce over 7 million tincture bottles per annum.
Supreme management expects the Blissco brand expansion to add meaningfully to sales during fiscal 2020, which began at the start of July.
Click here to receive an investor deck and corporate updates
Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ash Stringer
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Chemesis International is a vertically integrated global leader in the cannabis industry, currently operating within Puerto Rico, and California.
EuroMed Therapeutics is building the ninth Israeli licensed producer to capitalize on the domestic medical marijuana market and Europe’s nascent export market — worth upwards of $66 billion.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
